JW Lifescience Statistics
Total Valuation
JW Lifescience has a market cap or net worth of KRW 173.43 billion. The enterprise value is 233.04 billion.
Market Cap | 173.43B |
Enterprise Value | 233.04B |
Important Dates
The last earnings date was Monday, March 24, 2025.
Earnings Date | Mar 24, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
JW Lifescience has 15.48 million shares outstanding. The number of shares has increased by 0.02% in one year.
Current Share Class | n/a |
Shares Outstanding | 15.48M |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | -0.04% |
Owned by Insiders (%) | 0.11% |
Owned by Institutions (%) | 1.08% |
Float | 8.56M |
Valuation Ratios
The trailing PE ratio is 3.94.
PE Ratio | 3.94 |
Forward PE | n/a |
PS Ratio | 0.78 |
PB Ratio | 0.86 |
P/TBV Ratio | 1.41 |
P/FCF Ratio | 4.29 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.76, with an EV/FCF ratio of 5.77.
EV / Earnings | 5.30 |
EV / Sales | 1.05 |
EV / EBITDA | 3.76 |
EV / EBIT | 5.04 |
EV / FCF | 5.77 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.35.
Current Ratio | 1.32 |
Quick Ratio | 0.87 |
Debt / Equity | 0.35 |
Debt / EBITDA | 1.34 |
Debt / FCF | 1.71 |
Interest Coverage | 17.40 |
Financial Efficiency
Return on equity (ROE) is 24.45% and return on invested capital (ROIC) is 9.43%.
Return on Equity (ROE) | 24.45% |
Return on Assets (ROA) | 7.71% |
Return on Invested Capital (ROIC) | 9.43% |
Return on Capital Employed (ROCE) | 14.63% |
Revenue Per Employee | 739.13M |
Profits Per Employee | 146.14M |
Employee Count | 301 |
Asset Turnover | 0.77 |
Inventory Turnover | 5.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.67% in the last 52 weeks. The beta is 0.58, so JW Lifescience's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | -9.67% |
50-Day Moving Average | 10,765.00 |
200-Day Moving Average | 11,271.05 |
Relative Strength Index (RSI) | 53.65 |
Average Volume (20 Days) | 51,829 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JW Lifescience had revenue of KRW 222.48 billion and earned 43.99 billion in profits. Earnings per share was 2,841.00.
Revenue | 222.48B |
Gross Profit | 57.47B |
Operating Income | 35.86B |
Pretax Income | 59.03B |
Net Income | 43.99B |
EBITDA | 51.60B |
EBIT | 35.86B |
Earnings Per Share (EPS) | 2,841.00 |
Balance Sheet
The company has 9.62 billion in cash and 69.24 billion in debt, giving a net cash position of -59.62 billion or -3,850.03 per share.
Cash & Cash Equivalents | 9.62B |
Total Debt | 69.24B |
Net Cash | -59.62B |
Net Cash Per Share | -3,850.03 |
Equity (Book Value) | 200.44B |
Book Value Per Share | 12,949.63 |
Working Capital | 25.48B |
Cash Flow
In the last 12 months, operating cash flow was 50.69 billion and capital expenditures -10.31 billion, giving a free cash flow of 40.38 billion.
Operating Cash Flow | 50.69B |
Capital Expenditures | -10.31B |
Free Cash Flow | 40.38B |
FCF Per Share | 2,607.96 |
Margins
Gross margin is 25.83%, with operating and profit margins of 16.12% and 19.77%.
Gross Margin | 25.83% |
Operating Margin | 16.12% |
Pretax Margin | 26.53% |
Profit Margin | 19.77% |
EBITDA Margin | 23.19% |
EBIT Margin | 16.12% |
FCF Margin | 18.15% |
Dividends & Yields
This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 4.34%.
Dividend Per Share | 500.00 |
Dividend Yield | 4.34% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 17.60% |
Buyback Yield | -0.02% |
Shareholder Yield | 4.32% |
Earnings Yield | 25.36% |
FCF Yield | 23.29% |
Stock Splits
The last stock split was on April 20, 2018. It was a forward split with a ratio of 2.
Last Split Date | Apr 20, 2018 |
Split Type | Forward |
Split Ratio | 2 |
Scores
JW Lifescience has an Altman Z-Score of 2.6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.6 |
Piotroski F-Score | n/a |